formation of an ic with hydrophobic carrier, ta-β-cd, provided better in vitro/in vivo sustained release of fbr anthocyanins (16–24 and 97–99% cg + cr release, respectively, after 1 and 28 days from 20 wt% re:ta-β-cd ic/pla implants) over 1 month, owing to reduced polymer water uptake and porosity.